AU2001230589A1 - Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases - Google Patents

Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases

Info

Publication number
AU2001230589A1
AU2001230589A1 AU2001230589A AU3058901A AU2001230589A1 AU 2001230589 A1 AU2001230589 A1 AU 2001230589A1 AU 2001230589 A AU2001230589 A AU 2001230589A AU 3058901 A AU3058901 A AU 3058901A AU 2001230589 A1 AU2001230589 A1 AU 2001230589A1
Authority
AU
Australia
Prior art keywords
diseases
therapeutic
optic nerve
preventive agents
retinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230589A
Inventor
Eri Inoue
Tomiya Mano
Shunji Sogo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Tokyo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tokyo Pharmaceuticals Inc filed Critical Mitsubishi Tokyo Pharmaceuticals Inc
Publication of AU2001230589A1 publication Critical patent/AU2001230589A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001230589A 2000-02-09 2001-02-07 Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases Abandoned AU2001230589A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000031543 2000-02-09
JP2000-31543 2000-02-09
PCT/JP2001/000853 WO2001058487A1 (en) 2000-02-09 2001-02-07 Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases

Publications (1)

Publication Number Publication Date
AU2001230589A1 true AU2001230589A1 (en) 2001-08-20

Family

ID=18556283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230589A Abandoned AU2001230589A1 (en) 2000-02-09 2001-02-07 Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases

Country Status (2)

Country Link
AU (1) AU2001230589A1 (en)
WO (1) WO2001058487A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2536040C2 (en) * 2007-11-01 2014-12-20 Акусела Инк. Amine derivatives and their use for treatment of ophthalmological diseases and illnesses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69502539T2 (en) * 1994-03-18 1998-10-01 Senju Pharma Co Sarpogrelate-containing ophthalmic preparations for lowering intraocular pressure
JP4063341B2 (en) * 1994-07-06 2008-03-19 メイ株式会社 Glaucoma treatment and intraocular pressure-lowering agent

Also Published As

Publication number Publication date
WO2001058487A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2001288251A1 (en) Methods and devices for optical stimulation of neural tissues
EP1377232A4 (en) Ocular therapeutic agent delivery devices and methods for making and using such devices
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
AU4582797A (en) Methods for treatment of retinal diseases
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
EP1213018A4 (en) Preventive and therapeutic agents for eye diseases
AU2002307430A1 (en) Method and system for photodisruption of tissue of the eye
AU6391000A (en) Method of preventing the injury or death of retinal cells and treating ocular diseases
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
IL137429A0 (en) Methods and compsitions for treating diseases and conditions of the eye
AU2002227935A1 (en) Optical stimulation of the human eye
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
AU7106300A (en) Treatment of skin disorders
ZA200400210B (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
AU7449698A (en) Therapeutic agents for respiratory diseases
AU2001230589A1 (en) Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU3501100A (en) Synergistic combination for treatment of viral-mediated diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU1405001A (en) Treatment of diseases